tiprankstipranks
HLS Therapeutics Inc (TSE:HLS)
TSX:HLS
Canadian Market

HLS Therapeutics Inc (HLS) Income Statement

Compare
43 Followers

HLS Therapeutics Inc Income Statement

Last quarter (Q3 2024), HLS Therapeutics Inc's total revenue was $14.09M, a decrease of -12.17% from the same quarter last year. In Q3, HLS Therapeutics Inc's net income was $-4.84M. See HLS Therapeutics Inc’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 63.07M$ 61.47M$ 60.01M$ 56.11M$ 54.16M
Gross Profit
$ 55.45M$ 56.49M$ 56.04M$ 52.48M$ 52.23M
Operating Expenses
$ 55.45M$ 69.98M$ 62.32M$ 64.57M$ 56.86M
Depreciation and Amortization
$ 31.94M$ 34.40M$ 30.26M$ 33.19M$ 32.51M
EBITDA
$ 12.88M$ 18.00M$ 25.41M$ 23.19M$ 19.75M
Operating Income
$ -10.35M$ -13.44M$ -6.24M$ -11.26M$ -4.04M
Other Income/Expenses
$ -17.45M$ -10.22M$ -5.52M$ -4.21M$ -15.84M
Pretax Income
$ -27.80M$ -23.72M$ -11.81M$ -16.30M$ -20.46M
Net Income
$ -27.53M$ -23.60M$ -13.12M$ -15.33M$ -19.55M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -0.85$ -0.73$ -0.41$ -0.48$ -0.67
Diluted EPS
$ -0.85$ -0.73$ -0.41$ -0.48$ -0.67
Weighted Average Shares Outstanding
32.26M 32.33M 32.18M 31.71M 29.18M
Weighted Average Shares Outstanding (Diluted)
32.26M 32.43M 32.18M 31.71M 29.36M
Currency in USD

HLS Therapeutics Inc Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis